- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hitachi develops interventional Airis II
Hitachi Medical Systems America in Twinsburg, OH, has developed an interventional version of its Airis II open MRI scanner. The system has been installed in a specially designed suite at the Neuroscience Institute of the University Hospital in
Hitachi Medical Systems America in Twinsburg, OH, has developed an interventional version of its Airis II open MRI scanner. The system has been installed in a specially designed suite at the Neuroscience Institute of the University Hospital in Cincinnati, where radiologists are using it for both conventional imaging procedures as well as MR-guided surgical applications.
Hitachi's interventional package for Airis II uses special software and hardware to support surgical procedures, such as fluoroscopic imaging sequences, open-designed radio-frequency coils, a 20-in LCD monitor located in the imaging suite, and special non-ferromagnetic surgical tools. Hitachi plans to file a 510(k) application for the interventional package and sell it as an option for Airis II, according to Sheldon Schaffer, Hitachi vice president of marketing.
At the Neuroscience Institute, Hitachi has worked with the hospital to develop a special imaging suite for the system, which includes features such as a 20-inch deep pit in which surgeons and radiologists stand while performing imaging procedures. A custom stainless steel lift transports equipment in and out of the surgical pit, while a neurosurgical operating room is adjacent to the imaging suite.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
